EUVIMEDEUVIMED entdecken
Crossref

Early Diagnosis and Prompt Intervention with Liposomal Amphotericin and Surgery Prevents Morbidity and Mortality in Rhino-OrbitoMucormycosis

Sudhir Halikar

International Journal of Current Pharmaceutical Review and Research · 30.07.2026 · 18 (07)

DOI: 10.25258/ijcpr.18.7.102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.07.2026. Verfasst von Sudhir Halikar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rhino-orbito-cerebral mucormycosis is a life threatening, angioinvasive, opportunistic fungal infection often seen in immuno-compromised individuals. After the second wave of COVID-19, there was sudden upsurge of cases of Mucormycosis potentially due to associated Diabetes with very high blood sugar or ketoacidosis or steroid based treatment protocols. In the early part of epidemic, we came across cases of mucormycosis in advanced stage of disease like loss of vision, orbital involvement, intracranial extension, maxillary involvement with high morbidity and mortality.

Aim

The aim of the study is to emphasize the importance of early diagnosis and prompt intervention with empirical Amphotericin and surgical clearance of the disease.

Methods

In a retrospective analysis, 54 cases of mucormycosis in various stages of disease progression and complications presented to a tertiary care center over a period of 2 months between 1 April 2020 to 30 May 2020 during the second wave of COVID-19 were analyzed. Many cases of mucormycosis were diagnosed when the disease was limited to sinuses based on symptoms in patients suffering from COVID-19 and with diagnostic tools like diagnostic nasal endoscopy [DNE], CT and MRI imagining.

Results

Among 54 patients with COVID-19–associated mucormycosis, 81.4% were males and 90% had diabetes, with 89% demonstrating poor glycemic control. All patients had received corticosteroids for COVID19 treatment, including 56% with irrational steroid use in mild non-hypoxemic disease. Twenty-four patients presented with early sinonasal disease and achieved 100% survival following FESS, whereas 30 patients had advanced disease with orbital, palatal, or cerebral involvement, resulting in a survival rate of 56.7% and significant postoperative morbidity. Extensive surgical procedures, including orbital exenteration, craniotomy, and maxillectomy, were frequently required in advanced-stage disease.

Conclusion

COVID-19–associated mucormycosis emerged as a significant epidemic with high morbidity and mortality, particularly among diabetic patients with poor glycemic control. Early recognition, a high index of suspicion, and prompt treatment with intravenous amphotericin B and surgical debridement while disease remains confined to the sinuses are critical for improving survival and reducing long-term disability.

Zitieren

APA

Halikar, S. (2026). Early Diagnosis and Prompt Intervention with Liposomal Amphotericin and Surgery Prevents Morbidity and Mortality in Rhino-OrbitoMucormycosis. International Journal of Current Pharmaceutical Review and Research, 18(07). https://doi.org/10.25258/ijcpr.18.7.102

Vancouver

Halikar S. Early Diagnosis and Prompt Intervention with Liposomal Amphotericin and Surgery Prevents Morbidity and Mortality in Rhino-OrbitoMucormycosis. International Journal of Current Pharmaceutical Review and Research. 2026;18(07). doi:10.25258/ijcpr.18.7.102

BibTeX
@article{Halikar2026,
  author = {Halikar, Sudhir},
  title = {Early Diagnosis and Prompt Intervention with Liposomal Amphotericin and Surgery Prevents Morbidity and Mortality in Rhino-OrbitoMucormycosis},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {07},
  doi = {10.25258/ijcpr.18.7.102}
}
Kostenlos starten →